Condition: Type 2 Diabetes · Acute Myocardial Infarction · Acute Myocardial Infarction With ST Elevation · Sponsor: Imperial College London
Glucose monitoring after Acute Myocardial infarct in people with diabetes is a Dexcom funded study that is investigating whether the use of continuous glucose monitors (Dexcom ONE model) in people with type 2 diabetes facilitates time in glycaemic range in the 6 months after an acute myocardial infarction. As an exploratory outcome it will investigate whether time in glycaemic range is associated with changes in mortality and major adverse cardiac events in the 6 months after acute myocardial infarct.
This description comes directly from the study's public registry record.
Monika Reddy, MBChB, PhD · 020 3311 1062 · m.reddy@imperial.ac.uk
Nick Oliver, MB BS, BSc · nick.oliver@imperial.ac.uk
Always discuss trial participation with your own doctor first.
| Hammersmith Hospital inpatient cardiology services | London, United Kingdom | Recruiting |
Get one email when the public record changes — results posted, or the study's status changes. Nothing else, ever.
We email about this public record only. Unsubscribe anytime with one click. Never medical advice.
This page is independently generated by Eichor from the public ClinicalTrials.gov record and re-synced daily. It is not the sponsor's official website unless claimed. Nothing here is medical advice; eligibility is always determined by the study team — talk to your own doctor first.
Source record: clinicaltrials.gov/study/NCT05431296